Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Alanine | 15 | 2021 | 5687 | 0.68 | Why? |
| Adenosine Monophosphate | 12 | 2021 | 5652 | 0.64 | Why? |
| Emtricitabine | 4 | 2017 | 202 | 0.50 | Why? |
| Rilpivirine | 3 | 2017 | 65 | 0.49 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 952 | 0.44 | Why? |
| Adenine | 3 | 2017 | 463 | 0.40 | Why? |
| HIV-1 | 4 | 2017 | 3365 | 0.40 | Why? |
| Viremia | 1 | 2017 | 1020 | 0.39 | Why? |
| Tenofovir | 3 | 2017 | 449 | 0.38 | Why? |
| Drug Resistance, Viral | 4 | 2021 | 1083 | 0.37 | Why? |
| Benzoxazines | 2 | 2017 | 103 | 0.32 | Why? |
| Ebolavirus | 3 | 2020 | 834 | 0.28 | Why? |
| Anti-HIV Agents | 4 | 2017 | 2209 | 0.27 | Why? |
| Transcription Termination, Genetic | 1 | 2020 | 8 | 0.22 | Why? |
| Marburg Virus Disease | 1 | 2021 | 41 | 0.22 | Why? |
| Marburgvirus | 1 | 2021 | 71 | 0.21 | Why? |
| Alkynes | 2 | 2017 | 98 | 0.21 | Why? |
| Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 43 | 0.21 | Why? |
| HIV Infections | 4 | 2017 | 11620 | 0.19 | Why? |
| Virus Replication | 7 | 2021 | 14331 | 0.19 | Why? |
| Cyclopropanes | 2 | 2017 | 332 | 0.17 | Why? |
| Antiviral Agents | 9 | 2021 | 41703 | 0.15 | Why? |
| Interferon-beta | 1 | 2020 | 979 | 0.13 | Why? |
| Macaca mulatta | 2 | 2021 | 3716 | 0.13 | Why? |
| Antibodies, Monoclonal | 3 | 2021 | 8041 | 0.13 | Why? |
| Sf9 Cells | 2 | 2020 | 273 | 0.10 | Why? |
| DNA, Viral | 1 | 2019 | 2521 | 0.09 | Why? |
| Viral Nonstructural Proteins | 3 | 2021 | 4810 | 0.09 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2019 | 1475 | 0.09 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2020 | 8843 | 0.09 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.08 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.07 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.07 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Models, Molecular | 3 | 2021 | 7616 | 0.06 | Why? |
| Metabolic Clearance Rate | 1 | 2021 | 110 | 0.06 | Why? |
| Templates, Genetic | 1 | 2020 | 58 | 0.06 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.05 | Why? |
| Animals | 8 | 2021 | 78931 | 0.05 | Why? |
| Drug Tolerance | 1 | 2020 | 100 | 0.05 | Why? |
| Carboxylesterase | 1 | 2020 | 22 | 0.05 | Why? |
| Half-Life | 1 | 2021 | 298 | 0.05 | Why? |
| Drug Therapy, Combination | 3 | 2021 | 7268 | 0.05 | Why? |
| Toremifene | 1 | 2019 | 3 | 0.05 | Why? |
| Cell Line | 3 | 2021 | 12040 | 0.05 | Why? |
| Furans | 1 | 2021 | 156 | 0.05 | Why? |
| Spodoptera | 1 | 2020 | 220 | 0.05 | Why? |
| Verapamil | 1 | 2019 | 46 | 0.05 | Why? |
| Selective Estrogen Receptor Modulators | 1 | 2019 | 65 | 0.05 | Why? |
| Primary Cell Culture | 1 | 2021 | 501 | 0.05 | Why? |
| Whole Genome Sequencing | 2 | 2021 | 3239 | 0.05 | Why? |
| Triazines | 1 | 2021 | 246 | 0.05 | Why? |
| Tamoxifen | 1 | 2019 | 83 | 0.05 | Why? |
| Models, Chemical | 1 | 2020 | 332 | 0.05 | Why? |
| Nucleotides | 1 | 2020 | 212 | 0.05 | Why? |
| Amiodarone | 1 | 2019 | 110 | 0.04 | Why? |
| Pyrroles | 1 | 2021 | 292 | 0.04 | Why? |
| Thymidine | 1 | 2017 | 21 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2021 | 907 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2020 | 581 | 0.04 | Why? |
| Democratic Republic of the Congo | 1 | 2019 | 500 | 0.04 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.04 | Why? |
| Mink | 1 | 2021 | 399 | 0.04 | Why? |
| Adenosine | 1 | 2021 | 509 | 0.04 | Why? |
| Anti-Arrhythmia Agents | 1 | 2019 | 325 | 0.04 | Why? |
| Calcium Channel Blockers | 1 | 2019 | 367 | 0.04 | Why? |
| Virus Cultivation | 1 | 2019 | 579 | 0.04 | Why? |
| Lamivudine | 1 | 2017 | 210 | 0.04 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2017 | 309 | 0.04 | Why? |
| Secondary Prevention | 1 | 2020 | 762 | 0.04 | Why? |
| Mice, Knockout | 1 | 2020 | 1815 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.03 | Why? |
| Mitochondria | 1 | 2021 | 857 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Drug Interactions | 1 | 2021 | 1653 | 0.03 | Why? |
| RNA | 1 | 2020 | 1278 | 0.03 | Why? |
| Ribavirin | 1 | 2019 | 1182 | 0.03 | Why? |
| Sequence Analysis, DNA | 1 | 2021 | 2830 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2021 | 3776 | 0.03 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2019 | 27595 | 0.03 | Why? |
| Mice | 2 | 2021 | 21357 | 0.03 | Why? |
| Lung Injury | 1 | 2020 | 919 | 0.03 | Why? |
| Mutation | 2 | 2020 | 12376 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.02 | Why? |
| Humans | 12 | 2021 | 930598 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.02 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Female | 6 | 2020 | 380317 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
| Male | 5 | 2020 | 367725 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Phylogeny | 1 | 2019 | 13341 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Middle Aged | 2 | 2017 | 270681 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.00 | Why? |
Porter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(110)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(115)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_